株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の神経系市場における機会:発病率・有病率・外科手術数

United States, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

発行 Medtech Insight 商品コード 263761
出版日 ページ情報 英文 106 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
米国の神経系市場における機会:発病率・有病率・外科手術数 United States, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes
出版日: 2013年01月31日 ページ情報: 英文 106 Pages
概要

当レポートでは、米国における主な神経系疾患/障害の発生率・有病率・外科手術数について調査し、疾患別のデータおよび予測を提供しており、概略以下の構成でお届けします。

第1章 神経系疾患/障害の概要

  • アルツハイマー病
  • 筋萎縮性側索硬化症(ALS)
  • 双極性障害
  • うつ病
  • てんかん
  • 多発性硬化症(MS)
  • パーキンソン病
  • 統合失調症
  • 脳卒中

第2章 神経系・精神疾患/障害

  • アルツハイマー病
  • 筋萎縮性側索硬化症(ALS)
  • 脳血管疾患
  • てんかん
  • ハンチントン病
  • 水頭症
  • 多発性硬化症(MS)
  • 重症筋無力症(MG)
  • パーキンソン病
  • 精神疾患
    • 注意欠陥・多動性障害(ADHD)
    • 双極性障害
    • うつ病
    • 統合失調症

第3章 神経系外科手術

  • 脳卒中
  • 脳動脈瘤
  • 動静脈奇(AVM)
  • 脳・中枢神経系の腫瘍
  • 外傷性脳損傷
  • 水頭症・頭蓋内圧亢進
  • 脳神経外科手術
    • 脳脊髄液(CSF)シャント
    • 頸動脈血管内膜切除術(CEA)
    • 脳動脈瘤・動静脈奇形(AVM)外科クリップ
    • 脳動脈瘤・動静脈奇形(AVM)塞栓
    • 頸動脈ステント
    • 頭蓋内ステント

図表

目次
Product Code: A777

Neurological impairment encompasses a diverse range of progressive central nervous system disorders that often are associated with significant psychiatric morbidity and reduced quality of life. This report presents the prevalence and number of hospital discharges in the United States as well as the surgical procedure volumes for selected neurological diseases/disorders. Among the disorders covered by this report are Alzheimer's disease, amyotrophic lateral sclerosis, bipolar disorder, cerebral aneurysm, depression, epilepsy, hydrocephalus, multiple sclerosis, Parkinson's disease, schizophrenia, and stroke. Among the covered surgical procedures are cerebrospinal fluid shunting, carotid artery stenting, cerebral aneurysm and arteriovenous malformation clipping and embolization, and intracranial stenting.

Procedure volumes forecasts are for the years 2011-2017. Hospital discharges are for the years 1999-2009; disease prevalence figures (and incidence figures when available) are for the year 2011.

In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including the ALS Association, Alzheimer's Association, American Parkinson Disease Association, American Stroke Association, Brain Aneurysm Foundation, Centers for Disease Control and Prevention, Epilepsy Foundation, Hydrocephalus Association, Michael J. Fox Foundation, Multiple Sclerosis International Federation, National Center for Health Statistics, National Human Genome Research Institute, National Institute of Neurological Disorders and Stroke, National Multiple Sclerosis Society, and National Parkinson Foundation, among others.

Table of Contents

1. OVERVIEW OF NEUROLOGICAL DISEASES/DISORDER

  • 1.1. Alzheimer's Disease
  • 1.2. Amyotrophic Lateral Sclerosis
  • 1.3. Bipolar Disorder
  • 1.4. Depression
  • 1.5. Epilepsy
  • 1.6. Multiple Sclerosis
  • 1.7. Parkinson's Disease
  • 1.8. Schizophrenia
  • 1.9. Stroke
  • Exhibit 1-1: Neurosurgery, Procedure Volumes Forecast, by Type, 2011-2017
  • Exhibit 1-2: Neurological Diseases/Disorders, Hospital Discharges and Prevalence

2. NEUROLOGICal AND PSYCHIATRIC DISEASES/DISORDERS

  • 2.1. Alzheimer's Disease
    • 2.1.1. Etiology
    • 2.1.2. Epidemiology
  • 2.2. Amyotrophic Lateral Sclerosis
    • 2.2.1. Etiology
    • 2.2.2. Epidemiology
  • 2.3. Cerebrovascular Diseases/Disorders
    • 2.3.1. Arteriovenous Malformation
      • 2.3.1.1. Etiology
      • 2.3.1.2. Epidemiology
    • 2.3.2. Cerebral Aneurysm
      • 2.3.2.1. Etiology
      • 2.3.2.2. Epidemiology
    • 2.3.3. Stroke
      • 2.3.3.1. Etiology
      • 2.3.3.2. Epidemiology
  • 2.4. Epilepsy
    • 2.4.1. Etiology
    • 2.4.2. Epidemiology
  • 2.5. Huntington's Disease
    • 2.5.1. Etiology
    • 2.5.2. Epidemiology
  • 2.6. Hydrocephalus
    • 2.6.1. Etiology
    • 2.6.2. Epidemiology
  • 2.7. Multiple Sclerosis
    • 2.7.1. Etiology
    • 2.7.2. Epidemiology
  • 2.8. Myasthenia Gravis
    • 2.8.1. Etiology
    • 2.8.2. Epidemiology
  • 2.9. Parkinson's Disease
    • 2.9.1. Etiology
    • 2.9.2. Epidemiology
  • 2.10. Psychiatric Disorders
    • 2.10.1. Attention Deficient Hyperactivity Disorder
      • 2.10.1.1. Etiology
      • 2.10.1.2. Epidemiology
    • 2.10.2. Bipolar Disorder
      • 2.10.2.1. Etiology
      • 2.10.2.2. Epidemiology
    • 2.10.3. Depression
      • 2.10.3.1. Etiology
      • 2.10.3.2. Epidemiology
    • 2.10.4. Schizophrenia
      • 2.10.4.1. Etiology
      • 2.10.4.2. Epidemiology
  • Exhibit 2-1: Alzheimer's Disease, Facts and Figures, 1999-2009, and 2010 and 2011
  • Exhibit 2-2: Amyotrophic Lateral Sclerosis, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-3: Arteriovenous Malformation, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-4: Cerebral Aneurysm, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-5: Stroke, Facts and Figures, 1999-2009, and 2010 and 2011
  • Exhibit 2-6: Epilepsy, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-7: Huntington's Disease, Facts and Figures
  • Exhibit 2-8: Hydrocephalus, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-9: Multiple Sclerosis, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-10: Myasthenia Gravis, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-11: Parkinson's Disease, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-12: Percentage of Adults Experiencing Serious Psychological Distress, by Age and Gender
  • Exhibit 2-13: Attention Deficit Hyperactivity Disorder, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-14: Bipolar Disorder, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-15: Depression, Facts and Figures, 1999-2009, and 2011
  • Exhibit 2-16: Schizophrenia, Facts and Figures, 1999-2009, and 2011

3. NEUROSURGICAL PROCEDURES

  • 3.1. Stroke
    • 3.1.1. Hemorrhagic Stroke
    • 3.1.2. Ischemic Stroke
  • 3.2. Cerebral Aneurysm
  • 3.3. Arteriovenous Malformations
  • 3.4. Tumors of the Brain and Central Nervous System
  • 3.5. Traumatic Brain Injury
  • 3.6. Hydrocephalus and Increased Intracranial Pressure
  • 3.7. Neurosurgical Procedures
    • 3.7.1. Cerebrospinal Fluid Shunting and Drainage
      • 3.7.1.1. Procedure Volumes
    • 3.7.2. Carotid Endarterectomy
      • 3.7.2.1. Procedure Volumes
    • 3.7.3. Cerebral Aneurysm and Arteriovenous Malformation Surgical Clipping
      • 3.7.3.1. Procedure Volumes
    • 3.7.4. Cerebral Aneurysm and Arteriovenous Malformation Embolization
      • 3.7.4.1. Procedure Volumes
    • 3.7.5. Carotid Artery Stenting
      • 3.7.5.1. Carotid Revascularization Endarterectomy versus Stenting Trial Results
      • 3.7.5.2. Procedure Volumes
    • 3.7.6. Intracranial Stenting
      • 3.7.6.1. Procedure Volumes
  • Exhibit 3-1: Cerebrospinal Fluid Shunting, Procedure Volumes Forecast, 2011-2017
  • Exhibit 3-2: Carotid Endarterectomy, Procedure Volumes Forecast, 2011-2017
  • Exhibit 3-3: Cerebral Aneurysm and Arteriovenous Malformation Surgical Clipping, Procedure Volumes Forecast, 2011-2017
  • Exhibit 3-4: Cerebral Aneurysm and Arteriovenous Malformation Embolization, Procedure Volumes Forecast, 2011-2017
  • Exhibit 3-5: Distally Protected Carotid Artery Stenting, Procedure Volumes Forecast, 2011-2017
  • Exhibit 3-6: Intracranial Stenting, Procedure Volumes Forecast, 2011-2017
Back to Top